China@EuroPCR - New BRS for bifurcation lesion

With the collaboration of The China Interventional Therapeutics Conference (CIT), the PCR-CIT China Chengdu Valves Course and the Left Main and Coronary Bifurcation Summit (CBS)

Chairpersons: M. Chen, R. Gao, B. Xu, J. Fajadet
Operators: K. Dou, J. Qian
Medical Control Desk: B. Harbaoui
React@PCR Moderator: E. Ricottini
Speakers: R. Gao, B. Xu

Summary

Consult this session on new Bioresorbable scaffolds for bifurcation lesion with the collaboration of CIT, the PCR-CIT China Chengdu Valves Course and CBS, which includes a LIVE demonstration from Fu Wai Hospital, National Centre for Cardiovascular Diseases - Beijing, China.

Clinical case

A 58-year-old female with effort angina:
- LAD/Diag 1 bifurcation
- BRS implantation
- OCT assessment

Learning Objectives

  • To learn about a new thinner strut poly-L-lactic acid-based BRS from China
  • To share the optimal techniques of implantation with BRS
  • To learn how to use a BRS in the treatment of coronary bifurcation lesion

Presentations available when logged in:

  • Session objectives
  • END OF LIVE CASE TRANSMISSION
  • Session evaluation and key learnings